bioAffinity Technologies prices USD 4 million private placement at USD 0.47 per share unit

• bioAffinity Technologies priced a USD 4 million private placement, selling 8,462,027 common shares or pre-funded warrants.
• Investors also receive two warrants for up to 16,924,054 shares; warrant exercise price USD 0.47, exercisable after stockholder approval.
• Combined effective offering price set at USD 0.47 per share with warrants; pre-funded warrant structure priced at USD 0.47.
• Closing expected around Aug. 14, 2026, subject to customary conditions.
• WallachBeth Capital is sole placement agent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608130907BIZWIRE_USPR_____20260812_BW527659) on August 13, 2026, and is solely responsible for the information contained therein.